MetaADEDB 2.0 @ LMMD
LCZ 696
(ZASXKEGREHRXDL-CAWNUZPDSA-H)
Structure
SMILES
CCOC(=O)[C@@H](C[C@@H](Cc1ccc(cc1)c1ccccc1)NC(=O)CCC(=O)[O-])C.CCOC(=O)[C@@H](C[C@@H](Cc1ccc(cc1)c1ccccc1)NC(=O)CCC(=O)[O-])C.CCCCC(=O)N([C@H](C(=O)[O-])C(C)C)Cc1ccc(cc1)c1ccccc1c1[n-]nnn1.CCCCC(=O)N([C@H](C(=O)[O-])C(C)C)Cc1ccc(cc1)c1ccccc1c1[n-]nnn1.O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
Molecular Formula:
C96H120N12Na6O21
Molecular Weight:
1915.990
Log P:
10.3731
Hydrogen Bond Acceptor:
31
Hydrogen Bond Donor:
7
TPSA:
461.21
CAS Number(s):
N/A
Synonym(s)
1.
LCZ 696
2.
3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate
3.
LCZ-696
4.
LCZ696
5.
entresto
6.
sacubitril
7.
sacubitril-valsartan
8.
trisodium (3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate) hemipentahydrate
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HypotensionFAERS: 2742
Canada Vigilance: 23
Canada Vigilance
US FAERS
2DizzinessFAERS: 1840
Canada Vigilance: 21
Canada Vigilance
US FAERS
3FatigueFAERS: 1456
Canada Vigilance: 14
Canada Vigilance
US FAERS
4MalaiseFAERS: 1377
Canada Vigilance: 1
Canada Vigilance
US FAERS
5No adverse eventFAERS: 1168US FAERS
6Drug ineffectiveFAERS: 681
Canada Vigilance: 9
Canada Vigilance
US FAERS
7Weight decreasedFAERS: 681
Canada Vigilance: 1
Canada Vigilance
US FAERS
8AstheniaFAERS: 669
Canada Vigilance: 7
Canada Vigilance
US FAERS
9Wrong technique in product usage processFAERS: 635
Canada Vigilance: 3
Canada Vigilance
US FAERS
10AngioedemaFAERS: 478
Canada Vigilance: 6
Canada Vigilance
US FAERS
11Myocardial InfarctionFAERS: 465
Canada Vigilance: 1
Canada Vigilance
US FAERS
12Feeling abnormalFAERS: 460
Canada Vigilance: 1
Canada Vigilance
US FAERS
13Cerebrovascular accidentFAERS: 392
Canada Vigilance: 1
Canada Vigilance
US FAERS
14PruritusFAERS: 382
Canada Vigilance: 6
Canada Vigilance
US FAERS
15NasopharyngitisFAERS: 364
Canada Vigilance: 2
Canada Vigilance
US FAERS
16Peripheral swellingFAERS: 348
Canada Vigilance: 3
Canada Vigilance
US FAERS
17NauseaFAERS: 324
Canada Vigilance: 7
Canada Vigilance
US FAERS
18Ejection Fraction DecreasedFAERS: 319US FAERS
19Chest PainFAERS: 318
Canada Vigilance: 4
Canada Vigilance
US FAERS
20Blood potassium increasedFAERS: 312
Canada Vigilance: 5
Canada Vigilance
US FAERS
21Inappropriate schedule of drug administrationFAERS: 308US FAERS
22HeadacheFAERS: 279
Canada Vigilance: 1
Canada Vigilance
US FAERS
23Blood creatinine increasedFAERS: 278
Canada Vigilance: 14
Canada Vigilance
US FAERS
24PneumoniaFAERS: 256
Canada Vigilance: 3
Canada Vigilance
US FAERS
25Memory impairmentFAERS: 255US FAERS
26Diabetes MellitusFAERS: 252US FAERS
27Atrial FibrillationFAERS: 249US FAERS
28Product use in unapproved indicationFAERS: 235
Canada Vigilance: 1
Canada Vigilance
US FAERS
29HypersensitivityFAERS: 231
Canada Vigilance: 1
Canada Vigilance
US FAERS
30PainFAERS: 228
Canada Vigilance: 1
Canada Vigilance
US FAERS
31InfluenzaFAERS: 200
Canada Vigilance: 2
Canada Vigilance
US FAERS
32SyncopeFAERS: 193
Canada Vigilance: 9
Canada Vigilance
US FAERS
33Drug prescribing errorFAERS: 192US FAERS
34Acute kidney injuryFAERS: 183
Canada Vigilance: 23
Canada Vigilance
US FAERS
35Product prescribing errorFAERS: 180US FAERS
36SomnolenceFAERS: 178US FAERS
37Back PainFAERS: 177
Canada Vigilance: 3
Canada Vigilance
US FAERS
38ArthralgiaFAERS: 170US FAERS
39Prescribed underdoseFAERS: 168
Canada Vigilance: 1
Canada Vigilance
US FAERS
40Lip swellingFAERS: 167US FAERS
41Abdominal discomfortFAERS: 165
Canada Vigilance: 1
Canada Vigilance
US FAERS
42SwellingFAERS: 163US FAERS
43Therapeutic response unexpectedFAERS: 162US FAERS
44Inappropriate schedule of product administrationFAERS: 160
Canada Vigilance: 1
Canada Vigilance
US FAERS
45DehydrationFAERS: 157
Canada Vigilance: 4
Canada Vigilance
US FAERS
46Blood glucose increasedFAERS: 151
Canada Vigilance: 3
Canada Vigilance
US FAERS
47VomitingFAERS: 144
Canada Vigilance: 2
Canada Vigilance
US FAERS
48Visual ImpairmentFAERS: 143
Canada Vigilance: 1
Canada Vigilance
US FAERS
49AmnesiaFAERS: 132
Canada Vigilance: 1
Canada Vigilance
US FAERS
50Joint swellingFAERS: 123US FAERS
51Chest discomfortFAERS: 115US FAERS
52PalpitationsFAERS: 111
Canada Vigilance: 5
Canada Vigilance
US FAERS
53BronchitisFAERS: 107
Canada Vigilance: 3
Canada Vigilance
US FAERS
54General physical health deteriorationFAERS: 107
Canada Vigilance: 3
Canada Vigilance
US FAERS
55AnxietyFAERS: 103
Canada Vigilance: 2
Canada Vigilance
US FAERS
56Blood pressure fluctuationFAERS: 103US FAERS
57Cardiac ArrestFAERS: 101
Canada Vigilance: 4
Canada Vigilance
US FAERS
58AlopeciaFAERS: 97US FAERS
59StressFAERS: 95
Canada Vigilance: 2
Canada Vigilance
US FAERS
60Concomitant disease aggravatedFAERS: 92
Canada Vigilance: 1
Canada Vigilance
US FAERS
61UrticariaFAERS: 89
Canada Vigilance: 1
Canada Vigilance
US FAERS
62ArthritisFAERS: 86
Canada Vigilance: 1
Canada Vigilance
US FAERS
63DementiaFAERS: 85
Canada Vigilance: 1
Canada Vigilance
US FAERS
64Device malfunctionFAERS: 85US FAERS
65MyalgiaFAERS: 83
Canada Vigilance: 2
Canada Vigilance
US FAERS
66TremorFAERS: 83
Canada Vigilance: 3
Canada Vigilance
US FAERS
67LethargyFAERS: 81US FAERS
68Limb discomfortFAERS: 81US FAERS
69Incorrect dose administeredFAERS: 72US FAERS
70GoutFAERS: 71
Canada Vigilance: 2
Canada Vigilance
US FAERS
71DysphoniaFAERS: 70US FAERS
72Contraindicated product administeredFAERS: 69US FAERS
73ThrombosisFAERS: 68US FAERS
74Urinary tract infectionFAERS: 68
Canada Vigilance: 3
Canada Vigilance
US FAERS
75InfectionFAERS: 67
Canada Vigilance: 1
Canada Vigilance
US FAERS
76SepsisFAERS: 66
Canada Vigilance: 2
Canada Vigilance
US FAERS
77Angina PectorisFAERS: 59
Canada Vigilance: 3
Canada Vigilance
US FAERS
78Blood glucose decreasedFAERS: 59US FAERS
79ConstipationFAERS: 58
Canada Vigilance: 1
Canada Vigilance
US FAERS
80Gait inabilityFAERS: 57US FAERS
81Productive CoughFAERS: 56US FAERS
82DeafnessFAERS: 55US FAERS
83Oropharyngeal painFAERS: 55US FAERS
84ArthropathyFAERS: 53US FAERS
85Pericardial effusionFAERS: 53US FAERS
86Abdominal PainFAERS: 52
Canada Vigilance: 1
Canada Vigilance
US FAERS
87Apparent deathFAERS: 51US FAERS
88NervousnessFAERS: 51US FAERS
89SluggishnessFAERS: 51US FAERS
90Depressed moodFAERS: 50US FAERS
91Sudden deathFAERS: 50US FAERS
92Throat irritationFAERS: 49US FAERS
93InfarctionFAERS: 48US FAERS
94BlindnessFAERS: 47US FAERS
95DyspepsiaFAERS: 47
Canada Vigilance: 1
Canada Vigilance
US FAERS
96SinusitisFAERS: 47
Canada Vigilance: 1
Canada Vigilance
US FAERS
97VertigoFAERS: 47US FAERS
98Limb injuryFAERS: 46
Canada Vigilance: 1
Canada Vigilance
US FAERS
99Blood potassium decreasedFAERS: 45
Canada Vigilance: 2
Canada Vigilance
US FAERS
100HypokinesiaFAERS: 45US FAERS
101Blood creatine increasedFAERS: 44US FAERS
102Brain natriuretic peptide increasedFAERS: 44US FAERS
103CardiomegalyFAERS: 44US FAERS
104Musculoskeletal PainFAERS: 43US FAERS
105Blood urea increasedFAERS: 41
Canada Vigilance: 4
Canada Vigilance
US FAERS
106TachycardiaFAERS: 41US FAERS
107Back disorderFAERS: 40US FAERS
108Joint injuryFAERS: 39US FAERS
109Musculoskeletal discomfortFAERS: 38US FAERS
110DysuriaFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
111Cardiac dysfunctionFAERS: 36US FAERS
112PresyncopeFAERS: 36
Canada Vigilance: 2
Canada Vigilance
US FAERS
113AgitationFAERS: 35US FAERS
114Coronary Artery DiseaseFAERS: 35US FAERS
115WheezingFAERS: 35US FAERS
116Blood cholesterol increasedFAERS: 34US FAERS
117ChokingFAERS: 34US FAERS
118ErythemaFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
119Product use issueFAERS: 34US FAERS
120EpistaxisFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
121Urinary RetentionFAERS: 33US FAERS
122Blood sodium decreasedFAERS: 32US FAERS
123HypersomniaFAERS: 32US FAERS
124SneezingFAERS: 32US FAERS
125AphoniaFAERS: 31US FAERS
126AsthmaFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
127Sudden Cardiac DeathFAERS: 31US FAERS
128DysgeusiaFAERS: 29US FAERS
129AscitesFAERS: 28US FAERS
130Burning sensationFAERS: 28US FAERS
131ChillsFAERS: 28US FAERS
132FlatulenceFAERS: 28US FAERS
133Musculoskeletal stiffnessFAERS: 28US FAERS
134Neck PainFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
135Pulmonary congestionFAERS: 28US FAERS
136Ventricular FibrillationFAERS: 28US FAERS
137CataractFAERS: 27US FAERS
138Fluid overloadFAERS: 27
Canada Vigilance: 2
Canada Vigilance
US FAERS
139Respiratory FailureFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
140AphasiaFAERS: 26US FAERS
141BradycardiaFAERS: 25US FAERS
142DiscomfortFAERS: 25US FAERS
143Ejection fraction abnormalFAERS: 24US FAERS
144Renal painFAERS: 24US FAERS
145ThrombocytopeniaFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
146Acute myocardial infarctionFAERS: 23US FAERS
147CellulitisFAERS: 23US FAERS
148DisorientationFAERS: 23US FAERS
149Atrioventricular BlockFAERS: 22US FAERS
150Dry skinFAERS: 22US FAERS
151N-terminal prohormone brain natriuretic peptide increasedFAERS: 22US FAERS
152HypoxiaFAERS: 21US FAERS
153NephrolithiasisFAERS: 21US FAERS
154Ventricular arrhythmiaFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
155Blood potassium abnormalFAERS: 20US FAERS
156Mouth swellingFAERS: 20US FAERS
157Lower respiratory tract infectionFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
158Maternal exposure during pregnancyFAERS: 19US FAERS
159PancreatitisFAERS: 19US FAERS
160Poor peripheral circulationFAERS: 19US FAERS
161Rheumatoid ArthritisFAERS: 19US FAERS
162TinnitusFAERS: 19US FAERS
163Head discomfortFAERS: 18US FAERS
164Pulmonary EmbolismFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
165Septic ShockFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
166Blood urine presentFAERS: 17US FAERS
167Mental impairmentFAERS: 17US FAERS
168Oral painFAERS: 17US FAERS
169ThirstFAERS: 17US FAERS
170Ankle FractureFAERS: 16US FAERS
171Complication associated with deviceFAERS: 16US FAERS
172CystitisFAERS: 16US FAERS
173InflammationFAERS: 16US FAERS
174Muscle strainFAERS: 16US FAERS
175Nasal pruritusFAERS: 16US FAERS
176Respiratory arrestFAERS: 16US FAERS
177SciaticaFAERS: 16US FAERS
178Atrial FlutterFAERS: 15US FAERS
179Feeling ColdFAERS: 15US FAERS
180FractureFAERS: 15US FAERS
181Skin irritationFAERS: 15US FAERS
182Blood glucose abnormalFAERS: 14US FAERS
183Bone painFAERS: 14US FAERS
184Cardiac FlutterFAERS: 14US FAERS
185Electrolyte imbalanceFAERS: 14US FAERS
186Erectile dysfunctionFAERS: 14US FAERS
187LaryngitisFAERS: 14US FAERS
188OverweightFAERS: 14US FAERS
189Poor quality sleepFAERS: 14US FAERS
190AgeusiaFAERS: 13US FAERS
191AsphyxiaFAERS: 13US FAERS
192ColitisFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
193Device inappropriate shock deliveryFAERS: 13US FAERS
194Device related infectionFAERS: 13US FAERS
195DiverticulitisFAERS: 13US FAERS
196Initial insomniaFAERS: 13US FAERS
197Nipple painFAERS: 13US FAERS
198PhotophobiaFAERS: 13US FAERS
199PolyuriaFAERS: 13US FAERS
200Post procedural complicationFAERS: 13US FAERS
201Pulmonary HypertensionFAERS: 13US FAERS
202RhabdomyolysisFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
203ShockFAERS: 13US FAERS
204Alanine Aminotransferase IncreasedFAERS: 12
Canada Vigilance: 4
Canada Vigilance
US FAERS
205Aspartate Aminotransferase IncreasedFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
206Blood glucose fluctuationFAERS: 12US FAERS
207ChromaturiaFAERS: 12US FAERS
208FlushingFAERS: 12US FAERS
209GastritisFAERS: 12US FAERS
210HyperthyroidismFAERS: 12US FAERS
211Night sweatsFAERS: 12US FAERS
212OverdoseFAERS: 12US FAERS
213Product dispensing errorFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
214ApathyFAERS: 11US FAERS
215Blood pressure inadequately controlledFAERS: 11US FAERS
216Cardiac discomfortFAERS: 11US FAERS
217Cerebral disorderFAERS: 11US FAERS
218CystFAERS: 11US FAERS
219HerniaFAERS: 11US FAERS
220PsoriasisFAERS: 11US FAERS
221AneurysmFAERS: 10US FAERS
222AnuriaFAERS: 10US FAERS
223Disease ProgressionFAERS: 10US FAERS
224Drug dispensing errorFAERS: 10US FAERS
225Drug effect incompleteFAERS: 10US FAERS
226Expired product administeredFAERS: 10US FAERS
227FibromyalgiaFAERS: 10US FAERS
228General physical condition abnormalFAERS: 10US FAERS
229LazinessFAERS: 10US FAERS
230RestlessnessFAERS: 10US FAERS
231RetchingFAERS: 10US FAERS
232Skin UlcerFAERS: 10US FAERS
233Throat cancerFAERS: 10US FAERS
234AngerFAERS: 9US FAERS
235Blood cholesterol abnormalFAERS: 9US FAERS
236Carpal Tunnel SyndromeFAERS: 9US FAERS
237Creatinine renal clearance decreasedFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
238Eye irritationFAERS: 9US FAERS
239Fluid imbalanceFAERS: 9US FAERS
240Gamma-Glutamyltransferase IncreasedFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
241GlaucomaFAERS: 9US FAERS
242HepatitisFAERS: 9US FAERS
243HungerFAERS: 9US FAERS
244Mental status changesFAERS: 9US FAERS
245NeuralgiaFAERS: 9US FAERS
246PallorFAERS: 9US FAERS
247Respiratory distressFAERS: 9US FAERS
248White blood cell count decreasedFAERS: 9US FAERS
249AbasiaFAERS: 8US FAERS
250AnosmiaFAERS: 8US FAERS
251Choking sensationFAERS: 8US FAERS
252DiplopiaFAERS: 8US FAERS
253Eye painFAERS: 8US FAERS
254Food AllergyFAERS: 8US FAERS
255GastroenteritisFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
256Gastrointestinal infectionFAERS: 8US FAERS
257HypophagiaFAERS: 8US FAERS
258Meniscus injuryFAERS: 8US FAERS
259ParanoiaFAERS: 8US FAERS
260Pulmonary thrombosisFAERS: 8US FAERS
261StomatitisFAERS: 8US FAERS
262Supraventricular tachycardiaFAERS: 8US FAERS
263Urinary IncontinenceFAERS: 8US FAERS
264CyanosisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
265DysgraphiaFAERS: 7US FAERS
266Emotional disorderFAERS: 7US FAERS
267Emotional distressFAERS: 7US FAERS
268Feeling jitteryFAERS: 7US FAERS
269Joint stiffnessFAERS: 7US FAERS
270LymphomaFAERS: 7US FAERS
271Macular degenerationFAERS: 7US FAERS
272Peripheral artery occlusionFAERS: 7US FAERS
273Pulmonary FibrosisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
274Rotator cuff syndromeFAERS: 7US FAERS
275UlcerFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
276Vasoplegia syndromeFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
277Venous occlusionFAERS: 7US FAERS
278Viral upper respiratory tract infectionFAERS: 7US FAERS
279AcneFAERS: 6US FAERS
280Anaphylactic shockFAERS: 6US FAERS
281AppendicitisFAERS: 6US FAERS
282Blood creatinine abnormalFAERS: 6US FAERS
283Blood magnesium decreasedFAERS: 6US FAERS
284Creatinine renal clearance increasedFAERS: 6US FAERS
285DeliriumFAERS: 6US FAERS
286Ear discomfortFAERS: 6US FAERS
287Echocardiogram abnormalFAERS: 6US FAERS
288EndocarditisFAERS: 6US FAERS
289GangreneFAERS: 6US FAERS
290HyperphagiaFAERS: 6US FAERS
291IncontinenceFAERS: 6US FAERS
292Intestinal ObstructionFAERS: 6US FAERS
293LymphadenopathyFAERS: 6US FAERS
294Micturition frequency decreasedFAERS: 6US FAERS
295Muscle tightnessFAERS: 6US FAERS
296Musculoskeletal chest painFAERS: 6US FAERS
297NeutropeniaFAERS: 6US FAERS
298Pre-existing condition improvedFAERS: 6US FAERS
299ProteinuriaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
300Respiratory tract congestionFAERS: 6US FAERS
301SarcoidosisFAERS: 6US FAERS
302Temperature intoleranceFAERS: 6US FAERS
303Therapy non-responderFAERS: 6US FAERS
304Troponin increasedFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
305Vascular occlusionFAERS: 6US FAERS
306Ventricular hypokinesiaFAERS: 6US FAERS
307skin abrasionFAERS: 6US FAERS
308Aortic AneurysmFAERS: 5US FAERS
309ArteriosclerosisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
310BalanoposthitisFAERS: 5US FAERS
311Bipolar DisorderFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
312Blood alkaline phosphatase increasedFAERS: 5US FAERS
313Blood sodium increasedFAERS: 5US FAERS
314Blood triglycerides increasedFAERS: 5US FAERS
315Cardiac stress test abnormalFAERS: 5US FAERS
316Cardiovascular insufficiencyFAERS: 5US FAERS
317CholecystitisFAERS: 5US FAERS
318CholelithiasisFAERS: 5US FAERS
319CholestasisFAERS: 5US FAERS
320Cold sweatFAERS: 5US FAERS
321CryingFAERS: 5US FAERS
322Deep Vein ThrombosisFAERS: 5US FAERS
323Diabetes mellitus inadequate controlFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
324Disease recurrenceFAERS: 5US FAERS
325Drug effect delayedFAERS: 5US FAERS
326Drug ineffective for unapproved indicationFAERS: 5US FAERS
327DysarthriaFAERS: 5US FAERS
328DyslexiaFAERS: 5US FAERS
329Food PoisoningFAERS: 5US FAERS
330Gastrointestinal PainFAERS: 5US FAERS
331HyperventilationFAERS: 5US FAERS
332IleusFAERS: 5US FAERS
333Intervertebral Disc DegenerationFAERS: 5US FAERS
334Intervertebral disc compressionFAERS: 5US FAERS
335Irritable Bowel SyndromeFAERS: 5US FAERS
336LeukopeniaFAERS: 5US FAERS
337Metabolic acidosisFAERS: 5US FAERS
338NocturiaFAERS: 5US FAERS
339OnychoclasisFAERS: 5US FAERS
340Oropharyngeal discomfortFAERS: 5US FAERS
341PoisoningFAERS: 5US FAERS
342Procedural complicationFAERS: 5US FAERS
343Rash erythematousFAERS: 5US FAERS
344Renal tubular necrosisFAERS: 5US FAERS
345Retinal DetachmentFAERS: 5US FAERS
346Tooth LossFAERS: 5US FAERS
347Upper respiratory tract congestionFAERS: 5US FAERS
348Urine output increasedFAERS: 5US FAERS
349Vitreous floatersFAERS: 5US FAERS
350Acute Coronary SyndromeFAERS: 4US FAERS
351Altered state of consciousnessFAERS: 4US FAERS
352AmyloidosisFAERS: 4US FAERS
353AsthenopiaFAERS: 4US FAERS
354Blister ruptureFAERS: 4US FAERS
355Blood creatine phosphokinase increasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
356Blood iron decreasedFAERS: 4US FAERS
357Blood magnesium increasedFAERS: 4US FAERS
358Bowel movement irregularityFAERS: 4US FAERS
359BradyphreniaFAERS: 4US FAERS
360BronchospasmFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
361Cardiac function test abnormalFAERS: 4US FAERS
362Completed SuicideFAERS: 4US FAERS
363Decreased immune responsivenessFAERS: 4US FAERS
364Dental cariesFAERS: 4US FAERS
365DermatitisFAERS: 4US FAERS
366Electrocardiogram abnormalFAERS: 4US FAERS
367EpilepsyFAERS: 4US FAERS
368ErysipelasFAERS: 4US FAERS
369Euphoric moodFAERS: 4US FAERS
370Eye InfectionFAERS: 4US FAERS
371Food cravingFAERS: 4US FAERS
372Frustration tolerance decreasedFAERS: 4US FAERS
373Full blood count decreasedFAERS: 4US FAERS
374Gastric ulcerFAERS: 4US FAERS
375Gastrointestinal inflammationFAERS: 4US FAERS
376HypometabolismFAERS: 4US FAERS
377Intra-abdominal fluid collectionFAERS: 4US FAERS
378LacerationFAERS: 4US FAERS
379Lip and/or oral cavity cancerFAERS: 4US FAERS
380MyocarditisFAERS: 4US FAERS
381N-terminal prohormone brain natriuretic peptide decreasedFAERS: 4US FAERS
382Ocular discomfortFAERS: 4US FAERS
383OliguriaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
384Oral pruritusFAERS: 4US FAERS
385PancytopeniaFAERS: 4US FAERS
386Peripheral arterial occlusive diseaseFAERS: 4US FAERS
387PeritonitisFAERS: 4US FAERS
388Personality ChangeFAERS: 4US FAERS
389Post procedural infectionFAERS: 4US FAERS
390Post-Traumatic Stress DisorderFAERS: 4US FAERS
391Renal cystFAERS: 4US FAERS
392Right ventricular failureFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
393Skin lesionFAERS: 4US FAERS
394Stevens-Johnson SyndromeFAERS: 4US FAERS
395Suicide attemptFAERS: 4US FAERS
396Systolic dysfunctionFAERS: 4US FAERS
397Terminal stateFAERS: 4US FAERS
398Tongue discomfortFAERS: 4US FAERS
399ToothacheFAERS: 4US FAERS
400UnderweightFAERS: 4US FAERS
401Urine flow decreasedFAERS: 4US FAERS
402jaundiceFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
403muscle injuryFAERS: 4US FAERS
404nervous system disorderFAERS: 4US FAERS
405Allergic coughFAERS: 3US FAERS
406Atypical pneumoniaFAERS: 3US FAERS
407Benign Prostatic HyperplasiaFAERS: 3US FAERS
408Blood count abnormalFAERS: 3US FAERS
409Blood creatine abnormalFAERS: 3US FAERS
410Blood phosphorus increasedFAERS: 3US FAERS
411Blue Toe SyndromeFAERS: 3US FAERS
412Brain HypoxiaFAERS: 3US FAERS
413Cardiac procedure complicationFAERS: 3US FAERS
414Cardiac ventricular thrombosisFAERS: 3US FAERS
415Cerebral InfarctionFAERS: 3US FAERS
416Cerebrovascular InsufficiencyFAERS: 3US FAERS
417Clostridium difficile colitisFAERS: 3US FAERS
418Clostridium difficile infectionFAERS: 3US FAERS
419Concomitant disease progressionFAERS: 3US FAERS
420Contraindicated drug administeredFAERS: 3US FAERS
421Device battery issueFAERS: 3US FAERS
422Diabetic FootFAERS: 3US FAERS
423Drug DependenceFAERS: 3US FAERS
424DyscheziaFAERS: 3US FAERS
425EczemaFAERS: 3US FAERS
426EmbolismFAERS: 3US FAERS
427EructationFAERS: 3US FAERS
428Eye opacityFAERS: 3US FAERS
429FibrosisFAERS: 3US FAERS
430FormicationFAERS: 3US FAERS
431Gastric DilatationFAERS: 3US FAERS
432Gastrointestinal carcinomaFAERS: 3US FAERS
433Gastrointestinal hypermotilityFAERS: 3US FAERS
434Gastrointestinal motility disorderFAERS: 3US FAERS
435Gastrointestinal sounds abnormalFAERS: 3US FAERS
436HemiplegiaFAERS: 3US FAERS
437Hypertensive crisisFAERS: 3US FAERS
438HypothyroidismFAERS: 3US FAERS
439IncoherentFAERS: 3US FAERS
440Incorrect drug administration durationFAERS: 3US FAERS
441Incorrect route of drug administrationFAERS: 3US FAERS
442Infrequent bowel movementsFAERS: 3US FAERS
443Intentional product misuseFAERS: 3US FAERS
444Large intestine perforationFAERS: 3US FAERS
445Leriche SyndromeFAERS: 3US FAERS
446MalnutritionFAERS: 3US FAERS
447Medication ErrorFAERS: 3US FAERS
448Middle insomniaFAERS: 3US FAERS
449Muscle SpasticityFAERS: 3US FAERS
450Myocardial StunningFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
451Nephrotic SyndromeFAERS: 3US FAERS
452Nerve injuryFAERS: 3US FAERS
453OsteomyelitisFAERS: 3US FAERS
454OsteoporosisFAERS: 3US FAERS
455PetechiaeFAERS: 3US FAERS
456Polymyalgia RheumaticaFAERS: 3US FAERS
457Prescribed overdoseFAERS: 3US FAERS
458Product physical issueFAERS: 3US FAERS
459Product use complaintFAERS: 3US FAERS
460Protein-losing gastroenteropathyFAERS: 3US FAERS
461Psychiatric symptomFAERS: 3US FAERS
462Quality of life decreasedFAERS: 3US FAERS
463Radiation injuryFAERS: 3US FAERS
464Restless Legs SyndromeFAERS: 3US FAERS
465ScabFAERS: 3US FAERS
466Seasonal Affective DisorderFAERS: 3US FAERS
467Skin reactionFAERS: 3US FAERS
468Subcutaneous AbscessFAERS: 3US FAERS
469Thermal burnFAERS: 3US FAERS
470Thyroid hormones increasedFAERS: 3US FAERS
471Umbilical herniaFAERS: 3US FAERS
472Urinary hesitationFAERS: 3US FAERS
473Viral myocarditisFAERS: 3US FAERS
474Visual brightnessFAERS: 3US FAERS
475Vitamin D DeficiencyFAERS: 3US FAERS
476treatment failureFAERS: 3US FAERS
477Abdominal InfectionFAERS: 2US FAERS
478Abdominal sepsisFAERS: 2US FAERS
479Accidental overdoseFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
480Acute left ventricular failureFAERS: 2US FAERS
481AdenocarcinomaFAERS: 2US FAERS
482Adverse eventFAERS: 2US FAERS
483Alcohol poisoningFAERS: 2US FAERS
484Allergy to fermented productsFAERS: 2US FAERS
485Amyotrophic Lateral SclerosisFAERS: 2US FAERS
486AngiodermatitisFAERS: 2US FAERS
487Arterial InjuryFAERS: 2US FAERS
488Arthropod biteFAERS: 2US FAERS
489AtelectasisFAERS: 2US FAERS
490Atrial tachycardiaFAERS: 2US FAERS
491Autoimmune thyroiditisFAERS: 2US FAERS
492Bladder NeoplasmFAERS: 2US FAERS
493Bladder discomfortFAERS: 2US FAERS
494Blood albumin decreasedFAERS: 2US FAERS
495Blood chloride decreasedFAERS: 2US FAERS
496Blood creatine decreasedFAERS: 2US FAERS
497Blood creatinine decreasedFAERS: 2US FAERS
498Blood electrolytes decreasedFAERS: 2US FAERS
499Blood sodium abnormalFAERS: 2US FAERS
500Blood thyroid stimulating hormone increasedFAERS: 2US FAERS
501Blood triglycerides abnormalFAERS: 2US FAERS
502Brain natriuretic peptide abnormalFAERS: 2US FAERS
503Brain natriuretic peptide decreasedFAERS: 2US FAERS
504Breast tendernessFAERS: 2US FAERS
505Bronchial wall thickeningFAERS: 2US FAERS
506BronchiectasisFAERS: 2US FAERS
507BursitisFAERS: 2US FAERS
508Capillary nail refill test abnormalFAERS: 2US FAERS
509Cardiac DeathFAERS: 2US FAERS
510Cardiac HypertrophyFAERS: 2US FAERS
511Cardiac TamponadeFAERS: 2US FAERS
512Cardiac perforationFAERS: 2US FAERS
513Cardiac ventricular disorderFAERS: 2US FAERS
514Carotid artery occlusionFAERS: 2US FAERS
515Cerebral PalsyFAERS: 2US FAERS
516Cerebral ThrombosisFAERS: 2US FAERS
517Compression fractureFAERS: 2US FAERS
518ConfabulationFAERS: 2US FAERS
519Critical IllnessFAERS: 2US FAERS
520Depressed Level of ConsciousnessFAERS: 2US FAERS
521Depression suicidalFAERS: 2US FAERS
522Dermatologic examination abnormalFAERS: 2US FAERS
523Device FailureFAERS: 2US FAERS
524Device breakageFAERS: 2US FAERS
525Device electrical findingFAERS: 2US FAERS
526Device extrusionFAERS: 2US FAERS
527Diastolic dysfunctionFAERS: 2US FAERS
528Dreamy stateFAERS: 2US FAERS
529DyschromatopsiaFAERS: 2US FAERS
530DysphemiaFAERS: 2US FAERS
531EnteritisFAERS: 2US FAERS
532Enzyme level increasedFAERS: 2US FAERS
533Escherichia infectionFAERS: 2US FAERS
534Excessive cerumen productionFAERS: 2US FAERS
535ExophthalmosFAERS: 2US FAERS
536Extra dose administeredFAERS: 2US FAERS
537Eye allergyFAERS: 2US FAERS
538Facial paralysisFAERS: 2US FAERS
539Fibrin D dimer increasedFAERS: 2US FAERS
540Flank PainFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
541FrostbiteFAERS: 2US FAERS
542Genital HerpesFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
543Granulomatosis with polyangiitisFAERS: 2US FAERS
544Grip strength decreasedFAERS: 2US FAERS
545Guillain-Barre SyndromeFAERS: 2US FAERS
546Heart sounds abnormalFAERS: 2US FAERS
547Heart valve stenosisFAERS: 2US FAERS
548Heat StrokeFAERS: 2US FAERS
549Heat illnessFAERS: 2US FAERS
550Hepatic cancer stage IVFAERS: 2US FAERS
551Hepatic congestionFAERS: 2US FAERS
552Hepatitis CFAERS: 2US FAERS
553HepatomegalyFAERS: 2US FAERS
554HyperkeratosisFAERS: 2US FAERS
555HyperparathyroidismFAERS: 2US FAERS
556Hypertensive cardiomyopathyFAERS: 2US FAERS
557HypoventilationFAERS: 2US FAERS
558Idiopathic Pulmonary FibrosisFAERS: 2US FAERS
559Impaired gastric emptyingFAERS: 2US FAERS
560Impaired insulin secretionFAERS: 2US FAERS
561Incarcerated herniaFAERS: 2US FAERS
562Incorrect route of product administrationFAERS: 2US FAERS
563Intellectual DisabilityFAERS: 2US FAERS
564Intermittent ClaudicationFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
565Intestinal PerforationFAERS: 2US FAERS
566Iron deficiencyFAERS: 2US FAERS
567Jugular vein distensionFAERS: 2US FAERS
568Larynx irritationFAERS: 2US FAERS
569Left Ventricular HypertrophyFAERS: 2US FAERS
570LeukocytosisFAERS: 2US FAERS
571Ligament ruptureFAERS: 2US FAERS
572Limb fractureFAERS: 2US FAERS
573Lipoprotein (a) increasedFAERS: 2US FAERS
574Lung consolidationFAERS: 2US FAERS
575MYELODYSPLASTIC SYNDROMEFAERS: 2US FAERS
576Medical device site dischargeFAERS: 2US FAERS
577Medical device site infectionFAERS: 2US FAERS
578Mental FatigueFAERS: 2US FAERS
579Migraine with AuraFAERS: 2US FAERS
580MonoplegiaFAERS: 2US FAERS
581Motion SicknessFAERS: 2US FAERS
582MultimorbidityFAERS: 2US FAERS
583Multiple sclerosis relapseFAERS: 2US FAERS
584Muscular DystrophyFAERS: 2US FAERS
585Myocardial necrosis marker increasedFAERS: 2US FAERS
586MyoclonusFAERS: 2US FAERS
587Myoglobin blood increasedFAERS: 2US FAERS
588Nail bed tendernessFAERS: 2US FAERS
589Nasal discomfortFAERS: 2US FAERS
590Nonspecific reactionFAERS: 2US FAERS
591Ocular icterusFAERS: 2US FAERS
592Oral mucosal eruptionFAERS: 2US FAERS
593Ovarian cancer stage IVFAERS: 2US FAERS
594Oxygen consumption increasedFAERS: 2US FAERS
595Oxygen saturation abnormalFAERS: 2US FAERS
596Pain of skinFAERS: 2US FAERS
597Pancreatic carcinomaFAERS: 2US FAERS
598Peripheral artery thrombosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
599Pharyngeal swellingFAERS: 2US FAERS
600PharyngitisFAERS: 2US FAERS
601PleurisyFAERS: 2US FAERS
602Pleuritic painFAERS: 2US FAERS
603PolyneuropathyFAERS: 2US FAERS
604Post procedural discomfortFAERS: 2US FAERS
605Product substitution issueFAERS: 2US FAERS
606Protein total decreasedFAERS: 2US FAERS
607Protein total increasedFAERS: 2US FAERS
608Pulmonary arterial hypertensionFAERS: 2US FAERS
609Pulmonary painFAERS: 2US FAERS
610PurpuraFAERS: 2US FAERS
611Pyoderma GangrenosumFAERS: 2US FAERS
612SchizophreniaFAERS: 2US FAERS
613Secretion dischargeFAERS: 2US FAERS
614Sexual DysfunctionFAERS: 2US FAERS
615Sinus TachycardiaFAERS: 2US FAERS
616Skin PapillomaFAERS: 2US FAERS
617Skin lacerationFAERS: 2US FAERS
618SomnambulismFAERS: 2US FAERS
619Spinal column stenosisFAERS: 2US FAERS
620SpondylitisFAERS: 2US FAERS
621SunburnFAERS: 2US FAERS
622ThrombophlebitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
623ThyroiditisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
624Tongue pruritusFAERS: 2US FAERS
625Transaminases increasedFAERS: 2US FAERS
626Trigeminal NeuralgiaFAERS: 2US FAERS
627Troponin T increasedFAERS: 2US FAERS
628Unresponsive to stimuliFAERS: 2US FAERS
629Urinary tract obstructionFAERS: 2US FAERS
630UrinomaFAERS: 2US FAERS
631Vascular graft thrombosisFAERS: 2US FAERS
632Vascular stent occlusionFAERS: 2US FAERS
633Venous InjuryFAERS: 2US FAERS
634Venous stenosisFAERS: 2US FAERS
635Vital functions abnormalFAERS: 2US FAERS
636Vocal Cord ParalysisFAERS: 2US FAERS
637Waist circumference increasedFAERS: 2US FAERS
638Wound InfectionFAERS: 2US FAERS
639Abdominal tendernessFAERS: 1US FAERS
640Accidental deathFAERS: 1US FAERS
641Accidental exposure to productFAERS: 1US FAERS
642Accidental exposure to product by childFAERS: 1US FAERS
643AcidosisFAERS: 1US FAERS
644Acute respiratory failureFAERS: 1US FAERS
645AdrenalitisFAERS: 1US FAERS
646AgranulocytosisFAERS: 1US FAERS
647AgraphiaFAERS: 1US FAERS
648Air EmbolismFAERS: 1US FAERS
649AkinesiaFAERS: 1US FAERS
650Alcohol interactionFAERS: 1US FAERS
651AlexiaFAERS: 1US FAERS
652AlkalosisFAERS: 1US FAERS
653Allergic bronchitisFAERS: 1US FAERS
654Allergic eosinophiliaFAERS: 1US FAERS
655Allergic reaction to excipientFAERS: 1US FAERS
656Allergy to animalFAERS: 1US FAERS
657AmaurosisFAERS: 1US FAERS
658Ammonia abnormalFAERS: 1US FAERS
659Amnestic DisorderFAERS: 1US FAERS
660AmputationFAERS: 1US FAERS
661Amylase increasedFAERS: 1US FAERS
662Animal biteFAERS: 1US FAERS
663Anticoagulation drug level increasedFAERS: 1US FAERS
664Antinuclear antibody increasedFAERS: 1US FAERS
665Aortic Valve StenosisFAERS: 1US FAERS
666Aortic valve calcificationFAERS: 1US FAERS
667Arterial bypass occlusionFAERS: 1US FAERS
668Arterial insufficiencyFAERS: 1US FAERS
669Arterial thrombosisFAERS: 1US FAERS
670Arteriogram coronary abnormalFAERS: 1US FAERS
671Arthropod stingFAERS: 1US FAERS
672Asymmetric di-methylarginine abnormalFAERS: 1US FAERS
673Autonomic nervous system imbalanceFAERS: 1US FAERS
674BedriddenFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
675Bilirubin conjugated increasedFAERS: 1US FAERS
676Bladder dysfunctionFAERS: 1US FAERS
677Bladder painFAERS: 1US FAERS
678Bladder prolapseFAERS: 1US FAERS
679Bladder tamponadeFAERS: 1US FAERS
680BlepharospasmFAERS: 1US FAERS
681Blood blisterFAERS: 1US FAERS
682Blood chloride increasedFAERS: 1US FAERS
683Blood heavy metal abnormalFAERS: 1US FAERS
684Blood immunoglobulin E increasedFAERS: 1US FAERS
685Blood iron increasedFAERS: 1US FAERS
686Blood lactate dehydrogenase increasedFAERS: 1US FAERS
687Blood magnesium abnormalFAERS: 1US FAERS
688Blood pH increasedFAERS: 1US FAERS
689Blood pressure immeasurableFAERS: 1US FAERS
690Blood testosterone abnormalFAERS: 1US FAERS
691Blood testosterone decreasedFAERS: 1US FAERS
692Blood urea nitrogen/creatinine ratio increasedFAERS: 1US FAERS
693Blood viscosity decreasedFAERS: 1US FAERS
694Bone contusionFAERS: 1US FAERS
695Bone decalcificationFAERS: 1US FAERS
696Bone density decreasedFAERS: 1US FAERS
697Bone infarctionFAERS: 1US FAERS
698Bone swellingFAERS: 1US FAERS
699Brain DeathFAERS: 1US FAERS
700Brain stem thrombosisFAERS: 1US FAERS
701BronchiolitisFAERS: 1US FAERS
702Burn infectionFAERS: 1US FAERS
703CalcinosisFAERS: 1US FAERS
704Calcium deficiencyFAERS: 1US FAERS
705Capillary FragilityFAERS: 1US FAERS
706Carbon dioxide abnormalFAERS: 1US FAERS
707Carbon dioxide decreasedFAERS: 1US FAERS
708Carbon dioxide increasedFAERS: 1US FAERS
709Cardiac asthmaFAERS: 1US FAERS
710Cardiac cirrhosisFAERS: 1US FAERS
711Cardiac complication associated with deviceFAERS: 1US FAERS
712Cardiac infectionFAERS: 1US FAERS
713Cardiac neoplasm unspecifiedFAERS: 1US FAERS
714Cardiac sarcoidosisFAERS: 1US FAERS
715Cardiac valve replacement complicationFAERS: 1US FAERS
716Cardio-respiratory distressFAERS: 1US FAERS
717CarditisFAERS: 1US FAERS
718CatarrhFAERS: 1US FAERS
719Cerebral artery occlusionFAERS: 1US FAERS
720Cerebral ventricle dilatationFAERS: 1US FAERS
721Cervicobrachial syndromeFAERS: 1US FAERS
722Cervix carcinomaFAERS: 1US FAERS
723CheilitisFAERS: 1US FAERS
724Cheyne-Stokes RespirationFAERS: 1US FAERS
725CholangiocarcinomaFAERS: 1US FAERS
726Cholecystitis infectiveFAERS: 1US FAERS
727Chronic left ventricular failureFAERS: 1US FAERS
728ClaustrophobiaFAERS: 1US FAERS
729Clostridium colitisFAERS: 1US FAERS
730ClumsinessFAERS: 1US FAERS
731Complement factor C3 decreasedFAERS: 1US FAERS
732Complement factor C4 decreasedFAERS: 1US FAERS
733Congenital cystic kidney diseaseFAERS: 1US FAERS
734Congenital scoliosisFAERS: 1US FAERS
735ConjunctivitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
736Connective tissue inflammationFAERS: 1US FAERS
737Contraindicated drug prescribedFAERS: 1US FAERS
738Coronary no-reflow phenomenonFAERS: 1US FAERS
739Cortisol decreasedFAERS: 1US FAERS
740CyanopsiaFAERS: 1US FAERS
741Cystitis escherichiaFAERS: 1US FAERS
742Cytology abnormalFAERS: 1US FAERS
743Dacryostenosis acquiredFAERS: 1US FAERS
744Decreased ventricular afterloadFAERS: 1US FAERS
745DependenceFAERS: 1US FAERS
746Device damageFAERS: 1US FAERS
747Device dislocationFAERS: 1US FAERS
748Device lead damageFAERS: 1US FAERS
749Device occlusionFAERS: 1US FAERS
750Device pacing issueFAERS: 1US FAERS
751Device related sepsisFAERS: 1US FAERS
752Device related thrombosisFAERS: 1US FAERS
753Device use issueFAERS: 1US FAERS
754Diabetic KetoacidosisFAERS: 1US FAERS
755Diabetic NephropathyFAERS: 1US FAERS
756Diabetic blindnessFAERS: 1US FAERS
757Diabetic foot infectionFAERS: 1US FAERS
758Diabetic metabolic decompensationFAERS: 1US FAERS
759Diabetic ulcerFAERS: 1US FAERS
760Diaphragmatic HerniaFAERS: 1US FAERS
761Diet refusalFAERS: 1US FAERS
762Distributive shockFAERS: 1US FAERS
763Diverticular fistulaFAERS: 1US FAERS
764Diverticular perforationFAERS: 1US FAERS
765DroolingFAERS: 1US FAERS
766Drug ToleranceFAERS: 1US FAERS
767Drug administration errorFAERS: 1US FAERS
768Drug level changedFAERS: 1US FAERS
769Dry age-related macular degenerationFAERS: 1US FAERS
770Dry gangreneFAERS: 1US FAERS
771DysenteryFAERS: 1US FAERS
772EcchymosisFAERS: 1US FAERS
773Electrocardiogram QT interval abnormalFAERS: 1US FAERS
774Electrocardiogram changeFAERS: 1US FAERS
775EmpyemaFAERS: 1US FAERS
776Endometrial adenocarcinomaFAERS: 1US FAERS
777Enterococcal infectionFAERS: 1US FAERS
778Enterococcus test positiveFAERS: 1US FAERS
779Erythema MultiformeFAERS: 1US FAERS
780Essential TremorFAERS: 1US FAERS
781Exposure via partnerFAERS: 1US FAERS
782Extremity contractureFAERS: 1US FAERS
783Extremity necrosisFAERS: 1US FAERS
784Eyelid irritationFAERS: 1US FAERS
785Fibrin D dimer decreasedFAERS: 1US FAERS
786Fine motor delayFAERS: 1US FAERS
787Flail ChestFAERS: 1US FAERS
788Fluoride increasedFAERS: 1US FAERS
789FumblingFAERS: 1US FAERS
790Gastric infectionFAERS: 1US FAERS
791Gastric pH decreasedFAERS: 1US FAERS
792Gastroenteritis norovirusFAERS: 1US FAERS
793Gastrointestinal bacterial overgrowthFAERS: 1US FAERS
794Gastrointestinal hypomotilityFAERS: 1US FAERS
795Gaze palsyFAERS: 1US FAERS
796General physical condition decreasedFAERS: 1US FAERS
797Genital swellingFAERS: 1US FAERS
798GingivitisFAERS: 1US FAERS
799GlossitisFAERS: 1US FAERS
800Granulocyte count increasedFAERS: 1US FAERS
801HaematotoxicityFAERS: 1US FAERS
802Hair injuryFAERS: 1US FAERS
803Hallucinations, mixedFAERS: 1US FAERS
804Heart alternationFAERS: 1US FAERS
805Heart valve calcificationFAERS: 1US FAERS
806HemiparesisFAERS: 1US FAERS
807Hepatic EncephalopathyFAERS: 1US FAERS
808Hepatic infection bacterialFAERS: 1US FAERS
809Hepatic necrosisFAERS: 1US FAERS
810Hepatorenal SyndromeFAERS: 1US FAERS
811Hernia painFAERS: 1US FAERS
812High density lipoprotein increasedFAERS: 1US FAERS
813Hormone level abnormalFAERS: 1US FAERS
814HydrocephalusFAERS: 1US FAERS
815HydronephrosisFAERS: 1US FAERS
816HypercapniaFAERS: 1US FAERS
817HypercreatininaemiaFAERS: 1US FAERS
818HyperleukocytosisFAERS: 1US FAERS
819HypermetabolismFAERS: 1US FAERS
820Hypertensive emergencyFAERS: 1US FAERS
821Hypertensive heart diseaseFAERS: 1US FAERS
822Hypertrophic CardiomyopathyFAERS: 1US FAERS
823HypobarismFAERS: 1US FAERS
824HypoperfusionFAERS: 1US FAERS
825Hyporesponsive to stimuliFAERS: 1US FAERS
826Imaging procedure artifactFAERS: 1US FAERS
827Immune thrombocytopenic purpuraFAERS: 1US FAERS
828ImmunosuppressionFAERS: 1US FAERS
829Impaired driving abilityFAERS: 1US FAERS
830Impaired reasoningFAERS: 1US FAERS
831Impaired work abilityFAERS: 1US FAERS
832Implant site infectionFAERS: 1US FAERS
833Inability to afford medicationFAERS: 1US FAERS
834Incarcerated inguinal herniaFAERS: 1US FAERS
835Incision site pruritusFAERS: 1US FAERS
836Incorrect product formulation administeredFAERS: 1US FAERS
837Infected biteFAERS: 1US FAERS
838Injection site bruisingFAERS: 1US FAERS
839Injection site painFAERS: 1US FAERS
840Injection site vesiclesFAERS: 1US FAERS
841Inspiratory capacity decreasedFAERS: 1US FAERS
842Insulin-requiring type 2 diabetes mellitusFAERS: 1US FAERS
843Interleukin level increasedFAERS: 1US FAERS
844Intervertebral disc disorderFAERS: 1US FAERS
845Intracranial AneurysmFAERS: 1US FAERS
846Joint Range of Motion DecreasedFAERS: 1US FAERS
847Lactose IntoleranceFAERS: 1US FAERS
848LaryngospasmFAERS: 1US FAERS
849Lead dislodgementFAERS: 1US FAERS
850LeprosyFAERS: 1US FAERS
851Limb massFAERS: 1US FAERS
852Lip exfoliationFAERS: 1US FAERS
853Lip pruritusFAERS: 1US FAERS
854Lipase increasedFAERS: 1US FAERS
855Lipids abnormalFAERS: 1US FAERS
856LithiasisFAERS: 1US FAERS
857Localised intraabdominal fluid collectionFAERS: 1US FAERS
858Low density lipoprotein increasedFAERS: 1US FAERS
859Lung perforationFAERS: 1US FAERS
860Lupus NephritisFAERS: 1US FAERS
861Lupus pleurisyFAERS: 1US FAERS
862Lyme DiseaseFAERS: 1US FAERS
863Lymphocyte count decreasedFAERS: 1US FAERS
864MalabsorptionFAERS: 1US FAERS
865Malignant ascitesFAERS: 1US FAERS
866MenorrhagiaFAERS: 1US FAERS
867MesotheliomaFAERS: 1US FAERS
868Metabolic function test abnormalFAERS: 1US FAERS
869Metastatic NeoplasmFAERS: 1US FAERS
870MetrorrhagiaFAERS: 1US FAERS
871Microvascular coronary artery diseaseFAERS: 1US FAERS
872Mitral Valve StenosisFAERS: 1US FAERS
873Mixed liver injuryFAERS: 1US FAERS
874Monocyte count increasedFAERS: 1US FAERS
875Mood swingsFAERS: 1US FAERS
876Mouth BreathingFAERS: 1US FAERS
877Multiple SclerosisFAERS: 1US FAERS
878Muscle RigidityFAERS: 1US FAERS
879Myasthenia GravisFAERS: 1US FAERS
880MydriasisFAERS: 1US FAERS
881Myocardial fibrosisFAERS: 1US FAERS
882Myocardial necrosisFAERS: 1US FAERS
883Myoclonic EpilepsyFAERS: 1US FAERS
884MyositisFAERS: 1US FAERS
885MyotoniaFAERS: 1US FAERS
886Nail InfectionFAERS: 1US FAERS
887NarcolepsyFAERS: 1US FAERS
888NecrosisFAERS: 1US FAERS
889Negative thoughtsFAERS: 1US FAERS
890NephritisFAERS: 1US FAERS
891NitrituriaFAERS: 1US FAERS
892Non-cardiac chest painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
893Nutritional condition abnormalFAERS: 1US FAERS
894ObesityFAERS: 1US FAERS
895ObstructionFAERS: 1US FAERS
896Optic NeuritisFAERS: 1US FAERS
897Oral candidiasisFAERS: 1US FAERS
898Oral mucosal erythemaFAERS: 1US FAERS
899Oral mucosal exfoliationFAERS: 1US FAERS
900Oxygen consumption decreasedFAERS: 1US FAERS
901PCO2 increasedFAERS: 1US FAERS
902PO2 decreasedFAERS: 1US FAERS
903Pancreatic NeoplasmFAERS: 1US FAERS
904Paternal exposure during pregnancyFAERS: 1US FAERS
905Paternal exposure timing unspecifiedFAERS: 1US FAERS
906Pelvic PainFAERS: 1US FAERS
907Pelvic venous thrombosisFAERS: 1US FAERS
908PemphigusFAERS: 1US FAERS
909Perforated ulcerFAERS: 1US FAERS
910PeriarthritisFAERS: 1US FAERS
911Pericardial CystFAERS: 1US FAERS
912PericarditisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
913Periorbital swellingFAERS: 1US FAERS
914Peripheral arthritisFAERS: 1US FAERS
915Peripheral motor neuropathyFAERS: 1US FAERS
916Perirectal abscessFAERS: 1US FAERS
917PhlebitisFAERS: 1US FAERS
918Physical deconditioningFAERS: 1US FAERS
919PlagueFAERS: 1US FAERS
920PlasmacytomaFAERS: 1US FAERS
921PneumothoraxFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
922PolydipsiaFAERS: 1US FAERS
923PolymyositisFAERS: 1US FAERS
924Post procedural dischargeFAERS: 1US FAERS
925Post procedural fistulaFAERS: 1US FAERS
926Post procedural inflammationFAERS: 1US FAERS
927Post procedural myocardial infarctionFAERS: 1US FAERS
928Post procedural sepsisFAERS: 1US FAERS
929Post procedural swellingFAERS: 1US FAERS
930Post stroke depressionFAERS: 1US FAERS
931Post-tussive vomitingFAERS: 1US FAERS
932Pre-EclampsiaFAERS: 1US FAERS
933Precancerous skin lesionFAERS: 1US FAERS
934Premature MenopauseFAERS: 1US FAERS
935Prerenal failureFAERS: 1US FAERS
936Procalcitonin increasedFAERS: 1US FAERS
937Procedural failureFAERS: 1US FAERS
938Procedural hypotensionFAERS: 1US FAERS
939Product complaintFAERS: 1US FAERS
940Product contamination physicalFAERS: 1US FAERS
941Product prescribing issueFAERS: 1US FAERS
942Prostatic perforationFAERS: 1US FAERS
943Prostatic specific antigen decreasedFAERS: 1US FAERS
944Protein urine presentFAERS: 1US FAERS
945Prothrombin time ratio increasedFAERS: 1US FAERS
946Pseudomonal sepsisFAERS: 1US FAERS
947Psychological TraumaFAERS: 1US FAERS
948Pulmonary arterial pressure increasedFAERS: 1US FAERS
949RalesFAERS: 1US FAERS
950Red cell distribution width decreasedFAERS: 1US FAERS
951RegurgitationFAERS: 1US FAERS
952Renal Artery StenosisFAERS: 1US FAERS
953Renal aneurysmFAERS: 1US FAERS
954Renal massFAERS: 1US FAERS
955Renal tubular acidosisFAERS: 1US FAERS
956Respiratory ParalysisFAERS: 1US FAERS
957Retinal vascular occlusionFAERS: 1US FAERS
958Rheumatoid factor increasedFAERS: 1US FAERS
959RhinalgiaFAERS: 1US FAERS
960RhinitisFAERS: 1US FAERS
961Rhinovirus infectionFAERS: 1US FAERS
962RhonchiFAERS: 1US FAERS
963Right Ventricular DysfunctionFAERS: 1US FAERS
964Right atrial dilatationFAERS: 1US FAERS
965Rubber sensitivityFAERS: 1US FAERS
966Ruptured cerebral aneurysmFAERS: 1US FAERS
967Salt cravingFAERS: 1US FAERS
968Salt intoxicationFAERS: 1US FAERS
969SclerodermaFAERS: 1US FAERS
970Secondary hypertensionFAERS: 1US FAERS
971Senile dementiaFAERS: 1US FAERS
972SeromaFAERS: 1US FAERS
973Single functional kidneyFAERS: 1US FAERS
974Sinus headacheFAERS: 1US FAERS
975Sinus polypFAERS: 1US FAERS
976Skin WrinklingFAERS: 1US FAERS
977Skin squamous cell carcinoma metastaticFAERS: 1US FAERS
978Skin tightnessFAERS: 1US FAERS
979Sleep disorder due to a general medical conditionFAERS: 1US FAERS
980Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
981Slow response to stimuliFAERS: 1US FAERS
982Slow speechFAERS: 1US FAERS
983SnoringFAERS: 1US FAERS
984Soft Tissue InfectionFAERS: 1US FAERS
985Somatic symptom disorderFAERS: 1US FAERS
986Spinal StenosisFAERS: 1US FAERS
987Spinal column injuryFAERS: 1US FAERS
988Splenic RuptureFAERS: 1US FAERS
989Squamous cell carcinomaFAERS: 1US FAERS
990SteatohepatitisFAERS: 1US FAERS
991Steroid diabetesFAERS: 1US FAERS
992Stitch abscessFAERS: 1US FAERS
993Stool analysis abnormalFAERS: 1US FAERS
994Strangulated herniaFAERS: 1US FAERS
995Stroke in evolutionFAERS: 1US FAERS
996StubbornnessFAERS: 1US FAERS
997Subacute endocarditisFAERS: 1US FAERS
998Sweat gland infectionFAERS: 1US FAERS
999Synovial CystFAERS: 1US FAERS
1000TachyarrhythmiaFAERS: 1US FAERS
1001TensionFAERS: 1US FAERS
1002Therapeutic product effect incompleteFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1003Therapy cessationFAERS: 1US FAERS
1004Therapy changeFAERS: 1US FAERS
1005Therapy partial responderFAERS: 1US FAERS
1006ThrombocytosisFAERS: 1US FAERS
1007Thrombotic strokeFAERS: 1US FAERS
1008Thyroid hormones decreasedFAERS: 1US FAERS
1009Time perception alteredFAERS: 1US FAERS
1010Tongue bitingFAERS: 1US FAERS
1011Tongue blisteringFAERS: 1US FAERS
1012Tongue eruptionFAERS: 1US FAERS
1013Tongue movement disturbanceFAERS: 1US FAERS
1014Toxicity to various agentsFAERS: 1US FAERS
1015Tri-iodothyronine free decreasedFAERS: 1US FAERS
1016TrichorrhexisFAERS: 1US FAERS
1017Troponin I increasedFAERS: 1US FAERS
1018Ultrasound scan abnormalFAERS: 1US FAERS
1019Upper airway obstructionFAERS: 1US FAERS
1020Upper-airway cough syndromeFAERS: 1US FAERS
1021Urethral ObstructionFAERS: 1US FAERS
1022Urinary sediment presentFAERS: 1US FAERS
1023UveitisFAERS: 1US FAERS
1024Vaginal DischargeFAERS: 1US FAERS
1025Vascular Access ComplicationFAERS: 1US FAERS
1026Vascular insufficiencyFAERS: 1US FAERS
1027Vascular resistance systemic decreasedFAERS: 1US FAERS
1028Vascular ruptureFAERS: 1US FAERS
1029Vascular stenosisFAERS: 1US FAERS
1030VasculitisFAERS: 1US FAERS
1031Ventricular DysfunctionFAERS: 1US FAERS
1032Ventricular failureFAERS: 1US FAERS
1033Vertebral artery occlusionFAERS: 1US FAERS
1034Walking aid userFAERS: 1US FAERS
1035Walking distance test abnormalFAERS: 1US FAERS
1036White blood cell count abnormalFAERS: 1US FAERS
1037Wound dehiscenceFAERS: 1US FAERS
1038Wrong drug administeredFAERS: 1US FAERS
1039Wrong patient received productFAERS: 1US FAERS
1040Wrong product administeredFAERS: 1US FAERS
1041Wrong technique in device usage processFAERS: 1US FAERS
1042effusionFAERS: 1US FAERS
1043furuncleFAERS: 1US FAERS
1044kyphosisFAERS: 1US FAERS
1045ovarian neoplasmFAERS: 1US FAERS
1046Abdominal incarcerated herniaCanada Vigilance: 1Canada Vigilance
1047AbscessCanada Vigilance: 1Canada Vigilance
1048Blood thyroid stimulating hormone decreasedCanada Vigilance: 1Canada Vigilance
1049Cluster HeadacheCanada Vigilance: 1Canada Vigilance
1050MicroalbuminuriaCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.